Search for Clinical Trial Results

Neurofibromatosis 1 - 25 Studies Found
Status | Study |
Completed |
Study Name: Modifying Genes in Neurofibromatosis 1 Condition: Neurofibromatosis 1 Date: 2012-05-29 Interventions: Other: No intervention No intervention |
Completed |
Study Name: Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T Condition: Neurofibromatosis 1 Date: 2014-12-12 Interventions: Drug: Everolimus Everyone in the study will receive Everolimus at a starting dose of 10 mg daily and wil |
Completed |
Study Name: Reliability of Functional Outcome Measures in Neurofibromatosis 1 Condition: Neurofibromatosis 1, NF1 Date: 2015-06-19 |
Completed |
Study Name: Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) Condition: Neurofibromatosis 1 Date: 2006-07-13 Interventions:
|
Enrolling by invitation |
Study Name: Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1 Condition: Neurofibromatosis 1 Date: 2016-01-15 Interventions: Other: Blood sample 10 mL venous blood sample for analysis of plasma |
Completed |
Study Name: Internet Support Group for Parents of a Child With Neurofibromatosis Type 1 Condition: Neurofibromatosis 1 Date: 2014-05-31 |
Recruiting |
Study Name: Neurofibromatosis Type 1 Patient Registry Condition: Neurofibromatosis Type 1 Date: 2011-08-02 |
Completed |
Study Name: Effects of Physical Training on Bone and Muscle Quality, Muscle Strength, and Motor Coordination in Children With NF1 Condition: Neurofibromatosis Type 1 Date: 2010-01-26 Interventions: Other: Plyometric training program The intervention is a year long individualized plyometric exercise tr |
Recruiting |
Study Name: Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs) Condition:
Date: 2015-09-05 |
Active, not recruiting |
Study Name: A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1 Condition: Neurofibromatosis Type 1 Date: 2009-02-23 Interventions:
|